Yi Yang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
The Neutrophil Percentage to Albumin Ratio as an Independent Risk Factor for Severe Consciousness Disorders and In-Hospital Mortality Following Pulmonary Surgery.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: May 29, 2026
Chinese expert consensus on perioperative management of patients with resectable anaplastic lymphoma kinase-fusion non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 06, 2025
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203).
Journal: Clinical lung cancer
Published: January 22, 2025
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001).
Journal: Journal of hematology & oncology
Published: October 24, 2024
Neoadjuvant immune checkpoint inhibitor treatment + chemotherapy (vs. chemotherapy alone) for locally advanced non‑small cell lung cancer: A retrospective cohort study.
Journal: Oncology letters
Published: October 25, 2022
Lobe-specific Lymph Node Dissection for Clinical Stage IA Non-small-cell Lung Cancer: What do we know?
Journal: Clinical lung cancer
Published: December 10, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026